Article
Molecular markers for patients with thymic malignancies: not feasible at present?
Asian Pacific journal of cancer prevention : APJCP - 1 Jan 2014
Avci Nilufer, Cecener Gulsah, Deligonul Adem, Erturk Elif, Tunca Berrin, Egeli Unal, Tezcan Gulcin, Akyildiz Elif Ulker, Bayram Ahmet Sami, Gebitekin Cengiz, Kurt Ender, Evrensel Turkkan
Abstract excerpt
BACKGROUND: Thymomas and thymic carcinomas are rare malignancies and devising clinically effective molecular targeted therapies is a major clinical challenge. The aim of the study was to analyze BLC2 and vascular endothelial growth factor receptor (VEGFR) expression and KRAS and EGFR mutational status and to correlate them with the clinical characteristics of patients with thymomas and thymic carcinomas....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.